A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus

Sponsor
AstraZeneca (Industry)
Overall Status
Completed
CT.gov ID
NCT00263276
Collaborator
Bristol-Myers Squibb (Industry)
389
145
7
14
2.7
0.2

Study Details

Study Description

Brief Summary

The purpose of this clinical research study is to learn if BMS-512148 is effective in controlling blood sugar levels as determined by HbA1c and fasting plasma glucose in patients who have been diagnosed with Type 2 diabetes. Patients should first try to control their diabetes with diet and exercise and should not have previously been treated for their diabetes (very short periods of time are acceptable). The safety of BMS512148 will also be studied

Study Design

Study Type:
Interventional
Actual Enrollment :
389 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Evaluate the Safety and Efficacy of BMS-512148 as Monotherapy in Subjects With Type 2 Diabetes Mellitus Who Are Treatment Naive And Have Inadequate Glycemic Control on Diet and Exercise
Study Start Date :
Dec 1, 2005
Actual Primary Completion Date :
Feb 1, 2007
Actual Study Completion Date :
Feb 1, 2007

Arms and Interventions

Arm Intervention/Treatment
Experimental: Arm 1

Drug: dapagliflozin
Tablets, Oral, 2.5 mg, Once daily, 12 weeks.

Experimental: Arm 2

Drug: dapagliflozin
Tablets, Oral, 5 mg, Once daily, 12 weeks.

Experimental: Arm 3

Drug: dapagliflozin
Tablets, Oral, 10 mg, Once daily, 12 weeks.

Experimental: Arm 4

Drug: dapagliflozin
Tablets, Oral, 20 mg, Once daily, 12 weeks.

Experimental: Arm 5

Drug: dapagliflozin
Tablets, Oral, 50 mg, Once daily, 12 weeks.

Placebo Comparator: Arm 6

Drug: placebo
Tablets, Oral, 0 mg, Once daily, 12 weeks.

Active Comparator: Arm 7

Drug: metformin
Tablets, Oral, >/= 1500 mg, Once daily, 12 weeks.

Outcome Measures

Primary Outcome Measures

  1. Mean change from baseline in HbA1c compared to placebo. [at 12 weeks]

Secondary Outcome Measures

  1. Mean change from baseline in fasting plasma glucose, evaluate proportion of subjects who achieve a therapeutic response (HbA1c <7%); change from baseline in urinary glucose excretion [at Weeks 6 and 12]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 79 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with Type 2 diabetes mellitus with inadequate glycemic control on diet and exercise. HbA1c >= 7% and <=10%.

  • Patient either has not been previously treated with antihyperglycemic medication or has been treated for <30 days since diagnosis and has received less than 3 consecutive doses or 7 non-consecutive doses in the last 30 days.

  • C-peptide > 1.0 ng/ml

  • Body Mass Index <= 40 kg/m2

  • Serum creatinine < 1.5 mg/dL for men or < 1.4 mg/dL for women.

  • No overt proteinuria (microalbumin/creatinine ratio must be <300 mg/g

Exclusion Criteria:
  • Unstable renal disease

  • Patients with significant liver disease including chronic active hepatitis

  • Within the last 6 months has had any of the following cardiovascular event: myocardial infarction, unstable angina, unstable CHF,NYHA Class III or IV CHF, TIA, unstable arrhythmia or cardiac revascularization surgery.

  • Subjects with clinically significant anemia

Contacts and Locations

Locations

Site City State Country Postal Code
1 Local Institution Bayou La Batre Alabama United States
2 Local Institution Birmingham Alabama United States
3 Local Institution Huntsville Alabama United States
4 Local Institution Mobile Alabama United States
5 Local Institution Chandler Arizona United States
6 Local Institution Tucson Arizona United States
7 Local Institution Fayetteville Arkansas United States
8 Local Institution Hot Springs Arkansas United States
9 Local Institution Beverly Hills California United States
10 Local Institution Long Beach California United States
11 Local Institution Los Gatos California United States
12 Local Institution Mission Viejo California United States
13 Local Institution Orange California United States
14 Local Institution Redondo Beach California United States
15 Local Institution San Diego California United States
16 Local Institution Torrance California United States
17 Local Institution Colorado Springs Colorado United States
18 Local Institution Denver Colorado United States
19 Local Institution Boynton Beach Florida United States
20 Local Institution Brandon Florida United States
21 Local Institution Delray Beach Florida United States
22 Local Institution Holly Hill Florida United States
23 Local Institution Jacksonville Florida United States
24 Local Instiuttion Jacksonville Florida United States
25 Local Institution New Port Richey Florida United States
26 Local Institution Orlando Florida United States
27 Local Institution Ormond Beach Florida United States
28 Local Institution Augusta Georgia United States
29 Local Institution Blue Ridge Georgia United States
30 Local Institution Honolulu Hawaii United States
31 Local Institution Indianapolis Indiana United States
32 Local Institution Lafayette Indiana United States
33 Local Institution Arkansas City Kansas United States
34 Local Institution Baton Rouge Louisiana United States
35 Local Institution Columbia Maryland United States
36 Local Institution Elkton Maryland United States
37 Local Institution Sudbury Massachusetts United States
38 Local Institution Worcester Massachusetts United States
39 Local Institution Dearborn Michigan United States
40 Local Institution Royal Oak Michigan United States
41 Local Institution Brooklyn Center Minnesota United States
42 Local Insitution Edina Minnesota United States
43 Local Institution Minneapolis Minnesota United States
44 Local Institution Hattiesburg Mississippi United States
45 Local Institution Jackson Mississippi United States
46 Local Institution Chesterfield Missouri United States
47 Local Institution Kansas City Missouri United States
48 Local Institution St. Louis Missouri United States
49 Local Institution Scottsbluff Nebraska United States
50 Local Institution North Las Vegas Nevada United States
51 Local Institution Albuquerque New Mexico United States
52 Local Institution Alburquerque New Mexico United States
53 Local Institution Los Alamos New Mexico United States
54 Local Institution Albany New York United States
55 Local Institution Bronxville New York United States
56 Local Institution Camillus New York United States
57 Local Institution Cooperstown New York United States
58 Local Instiution New Hyde Park New York United States
59 Local Institution West Seneca New York United States
60 Local Institution Charlotte North Carolina United States
61 Local Institution High Point North Carolina United States
62 Local Institution Morehead City North Carolina United States
63 Local Institution Raleigh North Carolina United States
64 Local Institution Wilmington North Carolina United States
65 Local Institution Akron Ohio United States
66 Local Institution Beachwood Ohio United States
67 Local Institution Cincinnati Ohio United States
68 Local Institution Cleveland Ohio United States
69 Local Institution Dayton Ohio United States
70 Local Institution Mogadore Ohio United States
71 Local Institution Newark Ohio United States
72 Local Institution Zanesville Ohio United States
73 Local Institution Bethany Oklahoma United States
74 Local Institution Yukon Oklahoma United States
75 Local Institution Bend Oregon United States
76 Local Institution Eugene Oregon United States
77 Local Institution Hillsboro Oregon United States
78 Local Institution Portland Oregon United States
79 Local Institution Bensalem Pennsylvania United States
80 Local Institution Feasterville Pennsylvania United States
81 Local Institution Levittown Pennsylvania United States
82 Local Institution Morrisville Pennsylvania United States
83 Local Institution Reading Pennsylvania United States
84 Local Institution Cumberland Rhode Island United States
85 Local Institution Johnston Rhode Island United States
86 Local Institution Anderson South Carolina United States
87 Local Institution Simpsonville South Carolina United States
88 Local Institution Summerville South Carolina United States
89 Local Institution Taylors South Carolina United States
90 Local Institution Rapid City South Dakota United States
91 Local Institution Memphis Tennessee United States
92 Local Institution Nashville Tennessee United States
93 Local Institution Selmer Tennessee United States
94 Local Institution Austin Texas United States
95 Local Institution Bellaire Texas United States
96 Local Institution Bryan Texas United States
97 Local Institution El Paso Texas United States
98 Local Institution Houston Texas United States
99 Local Institution Irving Texas United States
100 Local Institution San Antonio Texas United States
101 Local Institution Salt Lake City Utah United States
102 Local Institution Burke Virginia United States
103 Local Institution Hampton Virginia United States
104 Local Institution Norfolk Virginia United States
105 Local Institution Richmond Virginia United States
106 Local Institution Virginia Beach Virginia United States
107 Local Institution Edmonds Washington United States
108 Local Institution Renton Washington United States
109 Local Institution Spokane Washington United States
110 Local Institution Vancouver Washington United States
111 Local Institution Milwaukee Wisconsin United States
112 Local Institution West Allis Wisconsin United States
113 Local Institution Calgary Alberta Canada
114 Local Institution Edmonton Alberta Canada
115 Local Institution Langley British Columbia Canada
116 Local Institution Surrey British Columbia Canada
117 Local Institution Vancouver British Columbia Canada
118 Local Institution Winnipeg Manitoba Canada
119 Local institution Bathurst New Brunswick Canada
120 Local Institution Moncton New Brunswick Canada
121 Local Institution St. John's New Brunswick Canada
122 Local Institution St. John's Newfoundland and Labrador Canada
123 Local Institution Corunna Ontario Canada
124 Local Institution Etobicoke Ontario Canada
125 Local Institution Kitchener Ontario Canada
126 Local Institution Newmarket Ontario Canada
127 Local Institution Sarnia Ontario Canada
128 Local Institution Toronto Ontario Canada
129 Local Institution Charlottetown Prince Edward Island Canada
130 Local Institution Drummondville Quebec Canada
131 Local Institution Granby Quebec Canada
132 Local Institution Greenfield Park Quebec Canada
133 Local Institution Rimouski Quebec Canada
134 Local Institution St-Leonard Quebec Canada
135 Local Institution Ste-Foy Quebec Canada
136 Local Institution Saskatoon Saskatchewan Canada
137 Local Institution Guadalajara Jalisco Mexico
138 Local Institution Zapopan Jalisco Mexico
139 Local Institution Cuernavaca Morelos Mexico
140 Local Institution Monterrey Nuevo Leon Mexico
141 Local Institution Aguascalientes Mexico
142 Local Institution Durango Mexico
143 Local Institution Caguas Puerto Rico
144 Local Institution Manati Puerto Rico
145 Local Institution San Juan Puerto Rico

Sponsors and Collaborators

  • AstraZeneca
  • Bristol-Myers Squibb

Investigators

  • Study Director: Bristol Myers Squibb, Bristol-Myers Squibb

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00263276
Other Study ID Numbers:
  • MB102-008
First Posted:
Dec 8, 2005
Last Update Posted:
Nov 17, 2016
Last Verified:
Nov 1, 2016

Study Results

No Results Posted as of Nov 17, 2016